title: Human papillomavirus vaccine: a boon or curse.
abstract: Cervical cancer is the second most common cancer among women worldwide, with about 493,000 new cases diagnosed annually. Of 274,000 deaths due to cervical cancer each year, more than 80% occur in developing countries, and this proportion is expected to increase to 90% by 2020. Up to 70% of sexually active women will become infected with human papilloma virus (HPV) during their lifetime. Even though screening reduces the risk of cervical cancer, it does not prevent HPV infection or development of precancerous lesions which need careful follow-up and often need excision. It was observed in a study, pre-adolescent vaccination alone reduced cancer incidence by 44% and was more effective than screening alone. A combined approach of pre-adolescent vaccination and screening of adult women was more effective than either alone. The high probability of acquiring HPV infection once, one has become sexually active raises the question of whether the vaccine will be effective if given to girls who have already been infected with HPV type 16 or 18. In April 2010, The Indian parliament's Standing Committee on Health, began probing the use of HPV vaccines in 2 states after the reported deaths of 7 girls, and concluded that "safety and rights of children were highly compromised and violated." Though the question of immunization of older girls and women deserves attention, from a public health perspective, the first priority in resource-poor settings would be to vaccinate young adolescent girls.
authors: a Department of Community Medicine; MMMC ; Solan , Himachal Pradesh , India.
authors: Sumit
authors: S
authors: Chawla
authors: Inderjeet
authors: I
authors: Singh
authors: Rambilas
authors: R
authors: Jain
authors: Bharti
authors: B
authors: Mehta
authors: Sneh
authors: S
authors: Kumari
authors: Soumya Swaroop
authors: SS
authors: Sahoo
mesh_terms: D000293:Adolescent; D005260:Female; D006801:Humans; D053918:Papillomavirus Vaccines / Q000191:economics / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control*; D014611:Vaccination / Q000191:economics
chemical_list: D053918:Papillomavirus Vaccines
keywords: HPV; cancer; screening; vaccination; vaccine